Tiratha Raj Singh.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sensing and Relayaing of the Autophagic Signal by the ULK1
SENSING AND RELAYING THE AUTOPHAGIC SIGNAL BY THE ULK1 KINASE COMPLEX by Cindy Puente A Dissertation Presented to the Faculty of the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center in Partial Fulfillment of the Requirement for the Degree of Doctor of Philosophy New York, NY May, 2016 __________________________ __________________________ Xuejun Jiang, PhD Date Dissertation Mentor Copyright © 2016 by Cindy Puente To my husband, son, family and friends for their indefinite love and support iii ABSTRACT Autophagy is a conserved catabolic process that utilizes a defined series of membrane trafficking events to generate a double-membrane vesicle termed the autophagosome, which matures by fusing to the lysosome. Subsequently, the lysosome facilitates the degradation and recycling of the cytoplasmic cargo. Autophagy plays a vital role in maintaining cellular homeostasis, especially under stressful conditions, such as nutrient starvation. As such, it is implicated in a plethora of human diseases, particularly age-related conditions such as neurodegenerative disorders. The long-term goals of this proposal were to understand the upstream molecular mechanisms that regulate the induction of mammalian autophagy and understand how this signal is transduced to the downstream, core machinery of the pathway. In yeast, the upstream signals that modulate the induction of starvation- induced autophagy are clearly defined. The nutrient-sensing kinase Tor inhibits the activation of autophagy by regulating the formation of the Atg1-Atg13-Atg17 complex, through hyper-phosphorylation of Atg13. However, in mammals, the homologous complex ULK1-ATG13-FIP200 is constitutively formed. As such, the molecular mechanism by which mTOR regulates mammalian autophagy is unknown. -
Coxsackievirus Infection Induces a Non-Canonical Autophagy Independent of the ULK and PI3K Complexes
www.nature.com/scientificreports OPEN Coxsackievirus infection induces a non‑canonical autophagy independent of the ULK and PI3K complexes Yasir Mohamud1,2, Junyan Shi1,2, Hui Tang1,3, Pinhao Xiang1,2, Yuan Chao Xue1,2, Huitao Liu1,2, Chen Seng Ng1,2 & Honglin Luo1,2* Coxsackievirus B3 (CVB3) is a single‑stranded positive RNA virus that usurps cellular machinery, including the evolutionarily anti‑viral autophagy pathway, for productive infections. Despite the emergence of double‑membraned autophagosome‑like vesicles during CVB3 infection, very little is known about the mechanism of autophagy initiation. In this study, we investigated the role of established autophagy factors in the initiation of CVB3‑induced autophagy. Using siRNA‑mediated gene‑silencing and CRISPR‑Cas9‑based gene‑editing in culture cells, we discovered that CVB3 bypasses the ULK1/2 and PI3K complexes to trigger autophagy. Moreover, we found that CVB3‑ induced LC3 lipidation occurred independent of WIPI2 and the transmembrane protein ATG9 but required components of the late‑stage ubiquitin‑like ATG conjugation system including ATG5 and ATG16L1. Remarkably, we showed the canonical autophagy factor ULK1 was cleaved through the catalytic activity of the viral proteinase 3C. Mutagenesis experiments identifed the cleavage site of ULK1 after Q524, which separates its N‑terminal kinase domain from C‑terminal substrate binding domain. Finally, we uncovered PI4KIIIβ (a PI4P kinase), but not PI3P or PI5P kinases as requisites for CVB3‑induced LC3 lipidation. Taken together, our studies reveal that CVB3 initiates a non‑canonical form of autophagy that bypasses ULK1/2 and PI3K signaling pathways to ultimately converge on PI4KIIIβ‑ and ATG5–ATG12–ATG16L1 machinery. -
Genetic and Neurodevelopmental Spectrum Of
Cognitive and behavioural genetics J Med Genet: first published as 10.1136/jmedgenet-2015-103451 on 17 March 2016. Downloaded from ORIGINAL ARTICLE Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy Cyril Mignot,1,2,3 Celina von Stülpnagel,4,5 Caroline Nava,1,6 Dorothée Ville,7 Damien Sanlaville,8,9,10 Gaetan Lesca,8,9,10 Agnès Rastetter,6 Benoit Gachet,6 Yannick Marie,6 G Christoph Korenke,11 Ingo Borggraefe,12 Dorota Hoffmann-Zacharska,13 Elżbieta Szczepanik,14 Mariola Rudzka-Dybała,14 Uluç Yiş,15 Hande Çağlayan,16 Arnaud Isapof,17 Isabelle Marey,1 Eleni Panagiotakaki,18 Christian Korff,19 Eva Rossier,20 Angelika Riess,21 Stefanie Beck-Woedl,21 Anita Rauch,22 Christiane Zweier,23 Juliane Hoyer,23 André Reis,23 Mikhail Mironov,24 Maria Bobylova,24 Konstantin Mukhin,24 Laura Hernandez-Hernandez,25 Bridget Maher,25 Sanjay Sisodiya,25 Marius Kuhn,26 Dieter Glaeser,26 Sarah Weckhuysen,6,27 Candace T Myers,28 Heather C Mefford,28 Konstanze Hörtnagel,29 Saskia Biskup,29 EuroEPINOMICS-RES MAE working group, Johannes R Lemke,30 Delphine Héron,1,2,3,4 Gerhard Kluger,4,5 Christel Depienne1,6 ▸ Additional material is ABSTRACT INTRODUCTION published online only. To view Objective We aimed to delineate the neurodevelopmental The human SYNGAP1 gene on chromosome please visit the journal online (http://dx.doi.org/10.1136/ spectrum associated with SYNGAP1 mutations and to 6p21.3 encodes the synaptic RAS-GTPase-activating jmedgenet-2015-103451). investigate genotype–phenotype correlations. protein 1, a protein of the post-synaptic density Methods We sequenced the exome or screened the exons (PSD) of glutamatergic neurons.12SYNGAP1 inter- For numbered affiliations see end of article. -
Translational Regulation of Syngap1 by FMRP Modulates NMDAR Mediated Signalling
bioRxiv preprint doi: https://doi.org/10.1101/345058; this version posted June 26, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Translational regulation of Syngap1 by FMRP modulates NMDAR mediated signalling Abhik Paul1#, Bharti Nawalpuri2#, Shruthi Sateesh1, Ravi S Muddashetty2, James P Clement1* 1 Neuroscience Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064. India Phone: +91-80-22082613 2 The Institute for Stem Cell Biology and Regenerative Medicine, GKVK post, Bellary Road, Bangalore 560065. India # Equal contribution * Corresponding author: Email: [email protected] Phone: +91-80-22082613 Number of Pages: 34 including figures Number of Figure: 5 main and 4 extended Figures Number of words for: Abstract:157 Introduction: 452 Discussion: 854 Conflict of Interest: The authors declare no competing financial interests Acknowledgement: This work was supported by grants to JPC by DST-SERB (SB/YS/LS- 215/2013), and to RSM in part, by Dept. of Biotechnology, India (BT/PR8723/AGR/36/776/2013, and BT/IN/Denmark/07/RSM/2015-2016), and intramural funds from both the Institutes. We thank Bhavana Kayyar, Utsa Bhaduri, and Vijay Kumar M J for technical support in our bioinformatics analysis, and Sudhriti Ghosh Dastidar for technical advice on Figure 4. Further, we thank Dr Ravi Manjithaya and his group, and Prof. Kaustuv Sanyal’s group for technical assistance. We also thank Prof MRS Rao, Prof Tapas K Kundu, 1 bioRxiv preprint doi: https://doi.org/10.1101/345058; this version posted June 26, 2018. -
SYNGAP1 Resource Guide
"Building Bridges of Hope to a Cure" An Overview of SYNGAP1 Basic Biology and Clinical Description 1012 14th Street NW, Suite 500 (240) 347-0302 Washington D.C. 20005 www.bridgesyngap.org Production and distribution of this resource are made possible by an educational grant from Building Bridges of Hope to a Cure" About Us 3 Our History 4 SYNGAP1-Normal Function 5 Uniqueness in SYNGAP1 6 Common Symptoms of SYNGAP1 7 Facts about SYNGAP1 Syndrome 8 Common Indications of SYNGAP1 Cognition, development and behavior 9 Characteristics of SYNGAP1 Epilepsy 10 What About CBD? 11 SYNGAP1 Centers of Excellence 12 R e f e r e n c e s 13 References Continued 14 CBD Cited References 15 Connect with Us 16 "Building Bridges of Hope to a Cure" Bridge the Gap – SYNGAP Education and Research Foundation is the leading organization advocating and raising funds for research and treatments for SYNGAP1. The Foundation has its origins in the USA, and now with international outreach, gathers critical information from SYNGAP1 patients worldwide. Bridge the Gap-SYNGAP Education and Research Foundation's mission is to improve the quality of life for people affected by SYNGAP1, provide family support, accelerating research and raising awareness Our Mission To raise awareness and educate the public about SYNGAP1 (MRD5), unite patient families while building a robust data registry and providing meaningful information to researchers. Our Vision To increase the diagnosis rate of SYNGAP1 patients worldwide and provide the expert care, improving the quality of life for our SYNGAP1 community while searching for treatments. Our Goals Increase Diagnosis Rate will improve patient experience and quality of life a standard of care and SYNGAP1 disease profile. -
12Q Deletions FTNW
12q deletions rarechromo.org What is a 12q deletion? A deletion from chromosome 12q is a rare genetic condition in which a part of one of the body’s 46 chromosomes is missing. When material is missing from a chromosome, it is called a deletion. What are chromosomes? Chromosomes are the structures in each of the body’s cells that carry genetic information telling the body how to develop and function. They come in pairs, one from each parent, and are numbered 1 to 22 approximately from largest to smallest. Additionally there is a pair of sex chromosomes, two named X in females, and one X and another named Y in males. Each chromosome has a short (p) arm and a long (q) arm. Looking at chromosome 12 Chromosome analysis You can’t see chromosomes with the naked eye, but if you stain and magnify them many hundreds of times under a microscope, you can see that each one has a distinctive pattern of light and dark bands. In the diagram of the long arm of chromosome 12 on page 3 you can see the bands are numbered outwards starting from the point at the top of the diagram where the short and long arms meet (the centromere). Molecular techniques If you magnify chromosome 12 about 850 times, a small piece may be visibly missing. But sometimes the missing piece is so tiny that the chromosome looks normal through a microscope. The missing section can then only be found using more sensitive molecular techniques such as FISH (fluorescence in situ hybridisation, a technique that reveals the chromosomes in fluorescent colour), MLPA (multiplex ligation-dependent probe amplification) and/or array-CGH (microarrays), a technique that shows gains and losses of tiny amounts of DNA throughout all the chromosomes. -
Endogenous Sirnas and Noncoding RNA-Derived Small Rnas Are Expressed in Adult Mouse Hippocampus and Are Up-Regulated in Olfactory Discrimination Training
Downloaded from rnajournal.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Endogenous siRNAs and noncoding RNA-derived small RNAs are expressed in adult mouse hippocampus and are up-regulated in olfactory discrimination training NEIL R. SMALHEISER,1 GIOVANNI LUGLI,1 JYOTHI THIMMAPURAM,2 EDWIN H. COOK,1 and JOHN LARSON1 1Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois 60612, USA 2W.M. Keck Center for Comparative and Functional Genomics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA ABSTRACT We previously proposed that endogenous siRNAs may regulate synaptic plasticity and long-term gene expression in the mammalian brain. Here, a hippocampal-dependent task was employed in which adult mice were trained to execute a nose-poke in a port containing one of two simultaneously present odors in order to obtain a reward. Mice demonstrating olfactory discrimination training were compared to pseudo-training and nose-poke control groups; size-selected hippocampal RNA was subjected to Illumina deep sequencing. Sequences that aligned uniquely and exactly to the genome without uncertain nucleotide assignments, within exons or introns of MGI annotated genes, were examined further. The data confirm that small RNAs having features of endogenous siRNAs are expressed in brain; that many of them derive from genes that regulate synaptic plasticity (and have been implicated in neuropsychiatric diseases); and that hairpin-derived endo-siRNAs and the 20- to 23-nt size class of small RNAs show a significant increase during an early stage of training. The most abundant putative siRNAs arose from an intronic inverted repeat within the SynGAP1 locus; this inverted repeat was a substrate for dicer in vitro, and SynGAP1 siRNA was specifically associated with Argonaute proteins in vivo. -
Syngap Families Welcome Packet Welcome
Syngap Families Welcome Packet Welcome We would like to extend you a warm welcome to the Syngap community. Getting a diagnosis is a big step! You finally have answers to the questions you have been asking. It could be that your child is young and you were not expecting the diagnosis… or you could have an older child and are just now finding answers after all these years. Feeling confused or overwhelmed is normal and expected. Please know that things are going to get better and we are here for you. So where do you go from here? Below are several steps we encourage you to take to learn more about Syngap. Given that Syngap is a rare neurological condition there is a great probability that your team of doctors have little or no knowledge about Syngap and how to treat it. You will soon become the Syngap specialist on your loved one’s care team and we are here to give you all the tools you need to be the best advocate. Where to start? Step 1: Basic understanding of Syngap and how it affects your loved one 1. Basic Introduction Syngap1 Syndrome is a rare genetic disorder caused by a mutation on the SYNGAP1 gene. It leads to several neurological issues in Syngap patients. Syngap1 was first diagnosed in 2009 by Dr Michaud at St Justine Hospital in Montreal. 2. Basic Genetics Syngap1 Syndrome is caused by a mutation on the SYNGAP1 gene (6p.21.32).The human body is made of trillions of cells. Each cell contains 23 pairs of chromosomes (46 total). -
The First International Conference on SYNGAP1-Related Brain Disorders
Weldon et al. Journal of Neurodevelopmental Disorders (2018) 10:6 DOI 10.1186/s11689-018-9225-1 REVIEW Open Access The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators Monica Weldon1, Murat Kilinc2, J. Lloyd Holder Jr3* and Gavin Rumbaugh2,4* Abstract Background: Pathologic mutations in SYNGAP1 cause a genetically defined form of intellectual disability (ID) with comorbid epilepsy and autistic features. While only recently discovered, pathogenicity of this gene is a relatively frequent genetic cause of classically undefined developmental delay that progresses to ID with commonly occurring comorbidities. Main body: A meeting of 150 people was held that included affected individuals and their caregivers, clinicians that treat this and related brain disorders, neuroscientists that study SYNGAP1 biology or the function of related genes, and representatives from government agencies that fund science and approve new medical treatments. The meeting focused on developing a consensus among all stakeholders as to how best to achieve a more fundamental and profound understanding of SYNGAP1 biology and its role in human disease. Short conclusion: From all of these proceedings, several areas of consensus emerged. The clinicians and geneticists agreed that the prevalence of epilepsy and sensory processing impairments in SYNGAP1-related brain disorders approached 100%. The neurobiologists agreed that more basic research is needed to better understand the molecular and cellular functions of the Syngap1 gene, which will lead to targets for therapeutic intervention. Finally, everyone agreed that there is a pressing need to form a robust patient registry as an initial step toward a prospective natural history study of patients with pathogenic SYNGAP1 variants. -
Regulation of ULK1 in Autophagy 2012 Stefan Ludwik Loska
Regulation of ULK1 in autophagy A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Life Sciences 2012 Stefan Ludwik Loska Table of Contents List of Figures...................................................................................................................6 Abstract.............................................................................................................................8 Declaration........................................................................................................................9 Copyright statement........................................................................................................10 Acknowledgements.........................................................................................................11 Autobiographical statement............................................................................................12 Abbreviations..................................................................................................................13 1. Introduction................................................................................................................19 1.1. Autophagy...........................................................................................................19 1.1.1. Role.............................................................................................................19 1.1.2. Mechanism..................................................................................................23 -
Characterization of Intellectual Disability and Autism Comorbidity Through Gene Panel Sequencing
bioRxiv preprint doi: https://doi.org/10.1101/545772; this version posted February 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Characterization of Intellectual disability and Autism comorbidity through gene panel sequencing Maria Cristina Aspromonte 1, 2, Mariagrazia Bellini 1, 2, Alessandra Gasparini 3, Marco Carraro 3, Elisa Bettella 1, 2, Roberta Polli 1, 2, Federica Cesca 1, 2, Stefania Bigoni 4, Stefania Boni 5, Ombretta Carlet 6, Susanna Negrin 6, Isabella Mammi 7, Donatella Milani 8 , Angela Peron 9, 10, Stefano Sartori 11, Irene Toldo 11, Fiorenza Soli 12, Licia Turolla 13, Franco Stanzial 14, Francesco Benedicenti 14, Cristina Marino-Buslje 15, Silvio C.E. Tosatto 3, 16, Alessandra Murgia 1, 2, Emanuela Leonardi 1, 2 1. Molecular Genetics of Neurodevelopment, Dept. of Woman and Child Health, University of Padova, Padova, Italy 2. Fondazione Istituto di Ricerca Pediatrica (IRP), Città della Speranza, Padova, Italy 3. Dept. of Biomedical Sciences, University of Padova, Padova, Italy 4. Medical Genetics Unit, Ospedale Universitario S. Anna, Ferrara, Italy 5. Medical Genetics Unit, S. Martino Hospital, Belluno, Italy 6. Child Neuropsychiatry Unit, IRCCS Eugenio Medea, Conegliano, Italy 7. Medical Genetics Unit, Dolo General Hospital, Venezia, Italy 8. Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, University of Milano, Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy 9. Child Neuropsychiatry Unit, Epilepsy Center, Santi Paolo-Carlo Hospital, Dept. of Health Sciences, University of Milano, Milano, Italy 10. Department of Pediatrics, Division of Medical Genetics, University of Utah School of Medicine, Salt Lake City, UT, USA 11. -
ER-Targeted Beclin 1 Supports Autophagosome Biogenesis in the Absence of ULK1 and ULK2 Kinases
cells Article ER-Targeted Beclin 1 Supports Autophagosome Biogenesis in the Absence of ULK1 and ULK2 Kinases Tahira Anwar 1, Xiaonan Liu 2 , Taina Suntio 3, Annika Marjamäki 1, Joanna Biazik 1, Edmond Y. W. Chan 4,5, Markku Varjosalo 2 and Eeva-Liisa Eskelinen 1,6,* 1 Molecular and Integrative Biosciences Research Programme, University of Helsinki, 00014 Helsinki, Finland; tahira.anwar@helsinki.fi (T.A.); [email protected] (A.M.); [email protected] (J.B.) 2 Institute of Biotechnology & HiLIFE, University of Helsinki, 00014 Helsinki, Finland; xiaonan.liu@helsinki.fi (X.L.); markku.varjosalo@helsinki.fi (M.V.) 3 Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland; taina.suntio@helsinki.fi 4 Department of Biomedical and Molecular Sciences and Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada; [email protected] 5 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK 6 Institute of Biomedicine, University of Turku, 20520 Turku, Finland * Correspondence: eeva-liisa.eskelinen@utu.fi; Tel.: +358-505115631 Received: 24 April 2019; Accepted: 15 May 2019; Published: 17 May 2019 Abstract: Autophagy transports cytoplasmic material and organelles to lysosomes for degradation and recycling. Beclin 1 forms a complex with several other autophagy proteins and functions in the initiation phase of autophagy, but the exact role of Beclin 1 subcellular localization in autophagy initiation is still unclear. In order to elucidate the role of Beclin 1 localization in autophagosome biogenesis, we generated constructs that target Beclin 1 to the endoplasmic reticulum (ER) or mitochondria. Our results confirmed the proper organelle-specific targeting of the engineered Beclin 1 constructs, and the proper formation of autophagy-regulatory Beclin 1 complexes.